The impact of the Human Immunodeficiency Virus (HIV) infection in colorectal surgical practice include the undoubted risk of surgeon's exposure, the atypical conditions that may be encountered and the outcome and long-term benefit of the surgical treatment on the background of the fact that Highly Active Antiretroviral Therapy (HAART)-compliant patients are living longer, but a progression of AIDS in the HAART-naïve patients. Thus, the author questions whether colorectal surgical procedures can be safe and effective measures in HIV/ AIDS patients and if surgical outcome is worthy of the surgeon's ethical responsibility to treat. Literature search on the Medline (PubMed) database, Cochrane library, science citation index, relevant chapters in specialized texts on original published studies on the impact of HIV/AIDS on colorectal surgery and, the author's colorectal work on HIV/AIDS patients in the sub-Saharan country, Cameroon, W/ Africa resulted in the following observations [1]. HIV/ AIDS patients are not a homogenous group. Clinical AIDS, lower CD4 counts and poor performance status are associated with poor surgical outcome. Anorectal complaints (40%) and abdominal pain (20%) are common [2]. The commonest disease processes-CMV colitis, B-cell lymphoma, acute appendicitis (CMV/ lymphoma-associated) and atypical mycobacterium avium intracellular (MAI) are associated with high level of immunosuppression and poor outcome [3]. Less than 1% require emergency laparotomy. Appendicectomy and colectomy are the commonest abdominal operations but emergency subtotal colectomy and ileostomy for toxic megacolon carries a high mortality. HAART improves resistance to infection, nutritional status and ability to withstand surgery but has not impacted on the anorectal disorders. Surgical interventions for life-threatening correctable